A controversial HHS document supporting RFK Jr.'s rollback of COVID vaccine guidance relies on disputed or misrepresented science, prompting outrage from health experts who call it “willful medical disinformation.”
The FDA has approved enflonsia, a fixed-dose monoclonal antibody, for preventing RSV lower respiratory tract disease in infants during their first season.
A MAHA commission report on child health cited several studies that could not be verified, leading to corrections and questions about sourcing accuracy.
The FDA has approved Khindivi, the first hydrocortisone oral solution for pediatric adrenal insufficiency, offering precise, ready-to-use dosing for patients aged 5 years and older.